Phase I/II Dose Escalation, Pharmacokinetic, Safety, and Efficacy Study of Oral Z-208 in Patients With Advanced Hepatocellular Carcinoma.
Phase of Trial: Phase I/II
Latest Information Update: 14 Oct 2015
At a glance
- Drugs Tamibarotene (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Jul 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 02 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2011 Planned end date changed from 1 Mar 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.